首页> 外国专利> Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma

Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma

机译:使用具有二氢羟氢醇和类似物的取代的六肝醇,以治疗肿瘤疾病和癌症干细胞,包括胶质母细胞瘤多形形和medulloblastoma

摘要

The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of glioblastoma multiforme and medulloblastoma. Dianhydrogalactitol acts as an alkylating agent on DNA that creates N7 methylation. Dianhydrogalactitol is effective in suppressing the growth of cancer stem cells and is active against tumors that are refractory to temozolomide; the drug acts independently of the MGMT repair mechanism.
机译:二氢化氢乳糖醇的使用提供了一种用于治疗胶质母细胞瘤和Medulloblastoma的新疗效。 二氢化氢乳糖醇作为在DNA上的烷基化剂,其产生N7甲基化。 二氢羟丙基乳糖醇有效地抑制癌症干细胞的生长,并针对对替莫唑胺难治的肿瘤有效; 该药独立于MGMT修复机制作用。

著录项

  • 公开/公告号US11234955B2

    专利类型

  • 公开/公告日2022-02-01

    原文格式PDF

  • 申请/专利权人 DEL MAR PHARMACEUTICALS (BC) LTD.;

    申请/专利号US201916242752

  • 发明设计人 DENNIS M. BROWN;JEFFREY BACHA;SANDRA DUNN;

    申请日2019-01-08

  • 分类号G01N33/48;G01N33/50;A61K31/336;A61K31/495;A61K31/047;C12Q1/6886;A61K47/54;A61K47/59;A61K47/62;A61K31/4188;A61K45/06;A61N5/10;

  • 国家 US

  • 入库时间 2022-08-24 23:35:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号